Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03621306
Other study ID # DXAPrecision
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 16, 2008
Est. completion date August 31, 2028

Study information

Verified date November 2023
Source Penn State University
Contact Mary Jane De Souza, PhD
Phone 814-863-0045
Email mjd34@psu.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of the study is to assess precision of the GE Lunar iDXA, Hologic Horizon W DXA scanner, and the Stratec peripheral quantitative computed tomography (pQCT) scanner. Aim 1: To assess standard deviation (SD) and coefficient of variation (CV) of testing bone mineral, bone geometry, and soft tissues in inanimate objects and adults. Tests on adults will be structured to assess: 1. Within- and between-day variability of testing 2. Within- and between-technician variability of testing 3. Variability due to positioning and post-scan processing 4. Variability due to different DXA scanning equipment Aim 2: To assess the least significant change (LSC) for testing bone mineral and soft tissues in adults. Aim 3: To assess strengths and limitations of DXA and pQCT testing, including sensitivity to movement, rate of re-rescanning, etc. which are crucial components for demonstrating feasibility in grant applications. Aim 4: To construct a database of DXA and pQCT test results and quality control procedures, showing our laboratory's quality control level.


Description:

Osteoporosis and obesity are highly prevalent and disabling chronic diseases. Osteoporosis is a disease of low bone mass, which predisposes people to bone fragility and increased risk of bone fractures. Obesity is a disease characterized by excess body fat levels, which predisposes people to diabetes, heart disease, stroke, hypertension, cancer, sleep apnea, osteoarthritis, and gallbladder disease. An essential component to research on the prevention and treatment of osteoporosis and obesity is a valid method for monitoring body fat levels and bone mineral density. Dual energy X-ray absorptiometry (DXA) is a method for analyzing bone mineral density and body composition, particularly bone mineral content, fat mass and lean mass in children and adults. DXA scanners use an X-ray tube to produce radiation, which is then filtered into low- and high-energy beams. These beams of radiation are emitted from beneath a table that the supine human body is lying on. The arm, which passes above the person, detects the attenuation of the radiation for each pixel the body occupies. Based on known attenuation levels of different human tissues, the imaging software provides information on the composition of each pixel of the body. These pixels are then summed to provide information on: total body bone mineral content, total bone mineral density, fat mass, and lean mass. The DXA can also assess regional body composition (e.g. trunk fat), which is of importance in evaluating health effects of body fatness patterns. Using standard protocols, bone mineral content and density can be assessed in areas of the body indicating high risk of fractures (e.g. hip and lumbar spine) or areas that are likely to be responsive to dietary or physical activity manipulations (e.g. lumbar spine and radius). Peripheral quantitative computed tomography (pQCT) is a 3-dimensional imaging technique that goes beyond the 2-dimensional imaging of DXA to assess both true volumetric bone density and bone geometry, the two key components of bone strength. Additionally, it can divide bone into its component parts, i.e. separately assessing bone density and bone geometry of cortical and trabecular bone. As such, the measurements obtained from pQCT provides a more complete picture of what may be occurring within bone tissue that contributes to either bone gain or bone loss, depending on the population and question of interest. pQCT assesses parameters of bone strength at the radius (forearm) and tibia (lower leg). A vital component of any clinical and research program is precision testing, which assesses the reproducibility of DXA and pQCT measurements within an individual technician and/or between multiple technicians. This study was designed to address our facility's needs and ethical requirement to complete precision testing. This precision testing is a necessary component of verifying the feasibility and validity of the method, as well as cross-calibrating DXA scanners in our multi-site studies. We are completing this testing with the two DXA scanners, the GE Lunar iDXA and the Hologic Horizon W DXA, as well as with the Stratec XCT 3000 pQCT. A vital component of any clinical and research program is precision testing, which assesses the reproducibility of DXA measurements within an individual technician and/or between multiple technicians. As alluded to above, the validity of bone and soft tissue measurements by DXA and pQCT is related to the skill of the technician in: 1) properly positioning the person before scanning and 2) properly analyzing the scan images afterward. Both of these components are subjective, requiring experience and feedback to improve technique. From an ethical standpoint, a level of technician competency is important in ensuring that both research volunteers and the technician are not exposed to radiation without the benefit of acceptable scan results. From a clinical and research standpoint, understanding the inherent variability in testing is an important component in planning and executing research studies having bone or body fat outcomes. As described the Conference of Radiation Control Program Directors, Inc. (CRCPD), and as established by the International Society of Bone Densitometry (ISCD), measurement of precision is a key component for assessing: 1. The smallest change (least significant change, LSC) in bone density that is biologically significant 2. The time interval between measurements necessary to detect changes. Precision testing requires that multiple scans be completed on individuals representative of the primary target population of interest, sometimes within a fairly short period of time. This exposure of additional radiation to a select group of individuals has created controversy about whether precision testing is necessary and ethical. The CRCPD and ISCD has fully supported precision testing, and recommended that it be a routine practice in all DXA sites. The CRCPD states that, "Some states without understanding the need for precision testing have prohibited the measurement despite low radiation doses and limited numbers of repeat densitometry determinations. Their major concern, of course, is the apparent unnecessary radiation to a few, select patients. To address the benefit versus risk issue, those exposed to the additional, small amount of radiation (equal to approximately an additional 6-12 hours of background radiation) are providing a benefit to themselves and all others by validating the results of bone mineral density (BMD) exams for that facility. Without precision testing, the BMD study is of no value resulting in thousands of patients being exposed to unnecessary radiation."


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date August 31, 2028
Est. primary completion date August 31, 2028
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Healthy adults of two age groups, 1) aged 18-40 or 2) aged >40yr. Exclusion Criteria: 1. for females, being pregnant 2. Having had X-ray procedures using contrast material in the previous 3 days 3. Having medical devices that interfere with scan accuracy 4. Wearing external metal objects that cannot be removed 5. Having internal metal objects 6. Body mass of > 450 lbs. 7. Having ostomies

Study Design


Related Conditions & MeSH terms


Intervention

Device:
DXA and pQCT precision testing
The participants are only being observed; there is no intervention other than DXA and pQCT testing for the purposes of looking at instrument/technician precision..

Locations

Country Name City State
United States Women's Health and Exercise Laboratories, The Pennsylvania State University University Park Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Penn State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Precision of iDXA BMD Standard Deviation and coefficient of variation for BMD measurements obtained on the GE Lunar iDXA One month
Primary Precision of Hologic Horizon W DXA BMD Standard Deviation and coefficient of variation for BMD measurements obtained on the Hologic Horizon W One month
Primary Precision of iDXA Body Composition Standard Deviation and coefficient of variation for body composition measurements obtained on the GE Lunar iDXA One month
Primary Precision of Hologic Horizon W DXA Body Composition Standard Deviation and coefficient of variation for body composition measurements obtained on the Hologic Horizon W One month
Primary Precision of the Stratec XCT 3000 pQCT Standard deviation and coefficient of variation for bone density, geometry, and estimated bone strength for the Stratec XCT 3000 pQCT One month
Secondary LSC for the iDXA BMD Least significant change for BMD using the GE Lunar iDXA One month
Secondary LSC for the Hologic Horizon W BMD Least significant change for BMD using the Hologic Horizon W DXA One month
Secondary LSC for the iDXA body composition Least significant change for body composition using the GE Lunar iDXA One month
Secondary LSC for the Hologic Horizon W body composition Least significant change for body composition using the Hologic Horizon W DXA One month
Secondary LSC for the Stratec XCT 3000 Least significant change for bone density, geometry, and estimated bone strength for the Stratec XCT 3000 One month
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05515835 - Relationship Between Effect Duration of Rocuronium and Body Composition Analysis Data.
Enrolling by invitation NCT05512559 - Body Composition Analysis and Time to Emergence From Remimazolam
Completed NCT04136821 - The Long-term Effects of Oceanix™ on Resistance Training Adaptations N/A
Completed NCT03432130 - Injury Occurrence in Hip-hop Dance N/A
Completed NCT04504799 - Validation of the New HAG-B19 Scale for Measuring Lean and Fat Body Masse
Withdrawn NCT04021446 - A Supervised Clinic-to-Community Exercise Intervention to Improve Cardiometabolic Health in Survivors of AYA Cancer N/A
Completed NCT02211612 - Overeating Different Fats and Influence on Muscle Mass and Body Fat Accumulation N/A
Completed NCT03412578 - Effect of Tactile/Kinaesthetic Massage Therapy on DXA Parameter of Preterm Infants N/A
Completed NCT02000492 - Frequent Ballgames Training for 9-11 Year Old Schoolchildren N/A
Completed NCT01209936 - Hydration Factor Study for the Stayhealthy BC3 N/A
Recruiting NCT06061315 - Effect of Collagen Peptides, in Combination With Resistance Training, on Body Composition and Muscle Strength in Untrained Men N/A
Completed NCT05730660 - Quercetin Phytosome® Chronic Fatigue Syndrome N/A
Recruiting NCT04969588 - Kinect Equations for Body Indices and Body Composition
Completed NCT04828655 - Analysis of Bioparametric Measures for Correlating Daily Habits and Reducing Blood Pressure N/A
Completed NCT04404413 - High-Intensity Interval Training and Intermittent Fasting on Body Composition and Physical Performance in Active Women N/A
Completed NCT05052164 - Improvement Of Physical And Physiological Parameters In Menopausal Or Post-Menopausal Celiac Women N/A
Completed NCT03352583 - Effects of Casein Timing on Body Composition and Performance N/A
Enrolling by invitation NCT03587233 - Are Women With Higher Professional Status More Sedentary Compared to Men? N/A
Recruiting NCT05556239 - STAY-STRONG Study of Exercise Training During Chemotherapy N/A
Active, not recruiting NCT04306523 - Early Genetic and Environmental Influences on Eating - The Baylor Infant Twins Study